Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Teva
US Army
Cipla
Boehringer Ingelheim

Generated: July 22, 2019

DrugPatentWatch Database Preview

Patent: 7,608,643

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,608,643
Title:Compounds for inhibiting KSP kinesin activity
Abstract: The present invention relates to compounds of Formula I or pharmaceutically acceptable salts or solvates thereof: ##STR00001## The present invention provides compositions comprising these compounds that are useful for treating cellular proliferative diseases or disorders associated with KSP kinesin activity and for inhibiting KSP kinesin activity.
Inventor(s): Doll; Ronald J. (Convent Station, NJ), Herbst; Ronald (Palo Alto, CA), Seghezzi; Wolfgang (Mountain View, CA), Lees; Emma M. (Oakland, CA), Estacio; William F. (San Lorenzo, CA)
Assignee: Schering Corporation (Kenilworth, NJ)
Application Number:11/370,005
Patent Claims:see list of patent claims

Details for Patent 7,608,643

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Imclone ERBITUX cetuximab VIAL; INTRAVENOUS 125084 001 2004-06-18 ➤ Try a Free Trial Schering Corporation (Kenilworth, NJ) ➤ Try a Free Trial RX Orphan search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Try a Free Trial Schering Corporation (Kenilworth, NJ) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Fish and Richardson
Mallinckrodt
UBS
McKesson
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.